Arakawa, Kenji
Tanabe Pharma Corporation (Japan)
2 papers on CoChatORCID 0000-0001-9900-9491
Most cited papers
- Verified
Factors affecting canagliflozin-induced transient urine volume increase in patients with type 2 diabetes mellitus
Tanaka, H., Takano, K., Iijima, H., Kubo, H., Maruyama, N., Hashimoto, T., Arakawa, K., Togo, M., Inagaki, N., & Kaku, K. (2017) · Advances in Therapy
Diabetes Treatment and ManagementHeart Failure Treatment and Management
Cited by 140
- Verified
Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice
Naznin, F., Sakoda, H., Okada, T., Tsubouchi, H., Waise, T. M. Z., Arakawa, K., & Nakazato, M. (2017) · European Journal of Pharmacology
Adipokines, Inflammation, and Metabolic DiseasesDiabetes Treatment and Management
Cited by 114
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free